The industry is projected to recover in 2024 after a decline in 2023. The life insurance sector in South Korea is seen to ...

GlobalData’s director of therapy research & analysis in medical devices says the new entity could make an attractive ...

A growing number of companies are dropping their targets following the election of Donald Trump for his second term.

As stores offer empty shelves and locked-up merchandise, the e-commerce giant makes itself convenient to budget-minded shoppers.

Early detection and public health interventions are critical in improving sepsis survival rates and limiting its long-term ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Non-alcoholic options could represent 40% of beer sales in a decade, Big Drop Brewing Co. suggests, arguing the market is “going in one direction”.

ITC has agreed to take over Prasuma to strengthen its presence in the fast-growing frozen, chilled and ready to cook foods space.

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

As the year-end approached, OEMs worked hard to achieve their annual targets, causing the market to heat up, reports Globaldata.

The Israel MoD DDR&D (MAFAT), has concluded a series of operational trials evaluating around 20 counter-drone technologies.

GlobalData said it would launch a 50 million-pound ($62.5 million) buyback program and that it intends to move its listing to the London Stock Exchange's main market from the AIM.